1. A method of inhibiting the proliferation of tumor cells, comprising contacting the tumor cells with cells of placental perfusate of a person. The method of claim 1, wherein the tumor cells are blood cancer cells. The method of claim 1, wherein the tumor cells are solid tumor cells. The method of claim 1, wherein the tumor cells are primary carcinoma cells from ductal epithelium, leukemia cells, acute T-cell leukemia cells, chronic myeloid lymphoma (CML) cells, acute myelogenous leukemia cells, chronic myelogenous leukemia (CML) cells, pulmonary cells carcinomas, colon adenocarcinoma cells, histiocytic lymphoma cells, colorectal carcinoma cells, colorectal adenocarcinoma cells or retinoblastoma cells. 5. The method of claim 1, wherein said placental perfusion solution is perfusion solution that is passed only through the vasculature of the placenta. The method according to claim 1, wherein said placental perfusate is passed through the vasculature of the placenta and collected from the maternal surface of the placenta. The method of claim 1, wherein said perfusate is prepared by passing a 0.9% NaCl solution through the vasculature of the placenta. The method of claim 1, wherein said perfusate comprises culture medium. The method of claim 1, wherein said perfusate is treated to remove a plurality of red blood cells. The method of claim 1, wherein said contacting is in vitro contacting. The method of claim 1, wherein said contacting is in vivo contacting. The method of claim 11, wherein said contacting occurs in a person. The method of claim 1, wherein said plurality of placental perfusion cells1. Способ подавления пролиферации опухолевых клеток, включающий контактирование опухолевых клеток с клетками плацентарного перфузата человека.2. Способ по п. 1, где опухолевыми клетками являются клетки рака крови.3. Способ по п. 1, где опухолевыми клетками являются клетки солидной опухоли.4. Способ по п. 1, где опухолевыми клетками являются клетки первичной карциномы из эпите
